Market Overview

Teva, Takeda Establish Partnership in Japan; Teva to Own 51% Stake, Takeda to Own 49% Stake

Related TEVA
Alibaba, JPMorgan, Teva: 'Fast Money' Picks For December 1
25 Stocks Moving In Friday's Pre-Market Session
FDA accepts Lilly's marketing application for migraine med galcanezumab (Seeking Alpha)

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Takeda
Pharmaceutical Company Limited (OTC: TKPYY)
today announced that the two companies have entered into a definitive
agreement to establish an unprecedented partnership in Japan. The
strategic move between Takeda, an R&D driven pharmaceutical company
which has a long history as a leading company in Japan, and Teva, among
the top ten pharmaceutical companies in the world and the global leader
in generics, will form a new business venture to meet the wide-ranging
needs of patients and growing importance of generics in Japan. As one of
the fastest growing generics markets in the world, Japan is expected to
continue its high growth driven by social requirements such as increased
patients' needs for

See full press release

Posted-In: News Contracts Press Releases


Related Articles (TEVA + TKPYY)

View Comments and Join the Discussion!

Partner Center